Trials / Completed
CompletedNCT02070367
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
Somatosensory Assessment and Rehabilitation of Allodynia: the SARA Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
This pilot study will test a new therapy, somatosensory rehabilitation, for the painful sensitivity experienced by persons with nerve injuries and/or complex regional pain syndrome (CRPS). Several methods for measuring pain and sensitivity that emphasize the person's evaluation of their own symptoms and the impact of these symptoms on their daily activities will also be tested to make sure they are consistent and accurate. Previous research has suggested one of the assessments may also be used to assist in the identification of CRPS: this simple test will be evaluated to see if it can accurately identify persons with this disorder (for which there is currently no diagnostic test). Together, this will improve treatment of CRPS through early, accurate diagnosis and the ability to measure important changes in this painful condition, and set up future studies for this new rehabilitation treatment method.
Detailed description
We will test four groups: persons with CRPS of one upper extremity, persons with recent hand fractures (\<12 weeks) or peripheral nerve injuries with residual sensory deficits at the time of the study, and healthy normal volunteers with a battery of assessments for CRPS, including a technique to precisely localize and quantify static mechanical allodynia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Somatosensory rehabilitation | |
| OTHER | Usual treatment: physiotherapy |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-05-01
- Completion
- 2017-06-01
- First posted
- 2014-02-25
- Last updated
- 2017-08-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02070367. Inclusion in this directory is not an endorsement.